URGN - UroGen Pharma GAAP EPS of -$0.68 beats by $0.17 revenue of $20.85M beats by $0.82M
2023-11-14 08:18:08 ET
More on UroGen Pharma
- UroGen Pharma's Financial And Clinical Symbiosis
- Seeking Alpha’s Quant Rating on UroGen Pharma
- Historical earnings data for UroGen Pharma
- Financial information for UroGen Pharma
For further details see:
UroGen Pharma GAAP EPS of -$0.68 beats by $0.17, revenue of $20.85M beats by $0.82M